Growth Metrics

Inogen (INGN) Cost of Revenue (2016 - 2022)

Inogen (INGN) has disclosed Cost of Revenue for 10 consecutive years, with $62.6 million as the latest value for Q3 2022.

  • On a quarterly basis, Cost of Revenue rose 121.16% to $62.6 million in Q3 2022 year-over-year; TTM through Sep 2022 was $120.6 million, a 33.86% decrease, with the full-year FY2021 number at $112.8 million, down 28.04% from a year prior.
  • Cost of Revenue was $62.6 million for Q3 2022 at Inogen, up from -$16.8 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $84.6 million in Q4 2020 to a low of -$40.9 million in Q4 2018.
  • A 5-year average of $30.1 million and a median of $28.0 million in 2019 define the central range for Cost of Revenue.
  • Biggest YoY gain for Cost of Revenue was 317.37% in 2018; the steepest drop was 144.18% in 2018.
  • Inogen's Cost of Revenue stood at -$40.9 million in 2018, then soared by 209.93% to $45.0 million in 2019, then surged by 88.09% to $84.6 million in 2020, then plummeted by 119.88% to -$16.8 million in 2021, then soared by 472.08% to $62.6 million in 2022.
  • Per Business Quant, the three most recent readings for INGN's Cost of Revenue are $62.6 million (Q3 2022), -$16.8 million (Q4 2021), and $28.3 million (Q3 2021).